Background. We aimed to determine whether arsenic exposure during pregnancy is associated with immune dysfunction and susceptibility to viral infection during pregnancy and postpartum in a low resource setting where host exposures to immunotoxic and infectious agents coexist.
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Methods. Since 2007, the JiVitA Research Project has prospectively followed the pregnancies of ∼60,000 women from Northern Bangladesh. In a sub-study of 1,100 pregnancies, IgG seroconversion to hepatitis E virus (HEV) was assessed between the 3 rd trimester (TM) and 3 months postpartum. 40 women seroconverted to HEV (cases) and were matched with 40 non-seroconverting women (controls) by age-, parity-, and sector of residence. For all 80 women, we assessed urinary concentrations of inorganic arsenic plus methylated species (InAs) (µg/L) at first and third TM and plasma concentrations of pro-and anti-inflammatory cytokines ( pg/ml) at first TM, third TM and 3 months postpartum.
Results. Among HEV seroconverters, urinary InAs was high throughout pregnancy (first TM median = 66 µg/L; interquartile range (IQR) = 41-132 µg/L; third TM median = 65 µg/L; IQR = 26-106 µg/L; p = 1.0), whereas among non-seroconverters urinary InAs declined significantly during pregnancy (first TM median = 62 µg/L; IQR = 37-82 µg/L; third TM median = 36 µg/L; IQR = 26-77 µg/L; p = 0.002). Among HEV seroconverters, first TM urinary InAs was positively associated with IL-2 in the first TM (beta per IQR-unit change in InAs = 0.29; p < 0.006) and subsequent time points (third TM beta = 0.33, p < 0.004; 3 months postpartum beta = 0.17; p < 0.03). The average of first and third TM urinary InAs was also positively associated with IL-2 among HEV seroconverters at third TM (beta = 0.27; p = 0.002) and 3 months postpartum (beta = 0.16; p = 0.005). Exposure-response associations between InAs and IL-2 were null among nonseroconverters.
Conclusion. Since HEV seroconversion occurred between third TM and 3 months post-partum, differential arsenic exposure during pregnancy increased susceptibility to subsequent viral infection. Cytokine shifts among HEV seroconverters suggest immune responses biologically consistent with arsenic-induced immune dysfunction and viral infection. Further investigation of arsenic's role in enhancing susceptibility to infection during pregnancy is needed, particularly immunotoxic and infectious synergies.
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